Her condition was refractory to standard-dose insulin infusion and deteriorated owing to renal failure.14) Habeb et al. reported a 71-year-old man with metastatic prostate cancer who developed DKA six months after starting capivasertib. This evidence concerns the gene INS and Renal insufficiency.